Results 81 to 90 of about 36,030 (253)
ABSTRACT Background and Aims SARS‐CoV‐2 continues to pose global challenges, and current vaccines face limitations (variant escape, waning immunity). This review evaluates immunostimulatory adjuvants and nano‐adjuvants to enhance immune responses and optimize SARS‐CoV‐2 vaccine performance.
Peyman Kheirandish Zarandi +5 more
wiley +1 more source
Anchoring of proteins to lactic acid bacteria [PDF]
The anchoring of proteins to the cell surface of lactic acid bacteria (LAB) using genetic techniques is an exciting and emerging research area that holds great promise for a wide variety of biotechnological applications. This paper reviews five different
A Hoick +66 more
core +1 more source
The characterization of EVs and viruses co‐purified by differential centrifugation highlighted their diversity. The 3K pellet contained viruses with high infectivity, along with DAP‐3 and mitochondrial DNA enriched EVs. A lower infectivity was associated with the 17K pellet. The 17K EVs displayed ICAM‐1 and contained HSP70 and mitochondrial DNA.
Julien Boucher +2 more
wiley +1 more source
Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41
Background We previously described the construction of an HIV-1 envelope glycoprotein complex (Env) that is stabilized by an engineered intermolecular disulfide bond (SOS) between gp120 and gp41.
Caffrey Michael +5 more
doaj +1 more source
Mining Alzheimer's Interactomes, Macromolecular Complexes and Pathways for Drug Discovery
ABSTRACT Alzheimer's disease (AD) is a progressive neurodegenerative disorder that leads to dementia. Many cases are diagnosed annually and there is no currently available cure. Understanding the underlying disease biology of AD through the study of molecular networks, particularly by mapping clinical variants to tissue‐specific interactomes and ...
Kalpana Panneerselvam +12 more
wiley +1 more source
A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity. [PDF]
The HIV vaccine strategy that, to date, generated immune protection consisted of a prime-boost regimen using a canarypox vector and an HIV envelope protein with alum, as shown in the RV144 trial.
Laura Pattacini +13 more
doaj +1 more source
bNAber: database of broadly neutralizing HIV antibodies. [PDF]
The discovery of broadly neutralizing antibodies (bNAbs) has provided an enormous impetus to the HIV vaccine research and to entire immunology. The bNAber database at http://bNAber.org provides open, user-friendly access to detailed data on the rapidly ...
Burton, Dennis R +8 more
core +4 more sources
Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential
Agonists of the cannabinoid 2 (CB2) receptor have shown promise for the treatment of pain in a variety of animal models. However, despite current preclinical evidence supporting the use of CB2 agonists for pain, successful translation of findings from preclinical models to human patients is lacking.
Kelsey G. Guenther, Andrea G. Hohmann
wiley +1 more source
HIV-1 replication is a tightly controlled mechanism which demands the interplay of host as well as viral factors. Both gp120 (envelope glycoprotein) and Nef (regulatory protein) have been correlated with the development of AIDS disease in independent ...
Roni Sarkar +2 more
doaj +1 more source
Molecular evolution of HIV-1 CRF01_AE Env in Thai patients. [PDF]
BACKGROUND: The envelope glycoproteins (Env), gp120 and gp41, are the most variable proteins of human immunodeficiency virus type 1 (HIV-1), and are the major targets of humoral immune responses against HIV-1.
Samatchaya Boonchawalit +11 more
doaj +1 more source

